多组分肺康复对80岁及以上长期机械通气患者的随机对照试验
这项单中心、评估者盲法的随机对照试验纳入≥80岁长期机械通气患者,随机分为多组分肺康复组或标准康复组,主要终点为成功脱机。意向性分析每组75例,多组分肺康复组45.3%成功脱机,标准康复组12.0%(校正HR 5.11;95%CI 2.46-11.23;P<.001)。干预组在30、60、90天时氧饱和度、膈肌增厚分数、咳嗽能力和肌力达到预设改善标准的 odds 更高,60天和90天VAP发生率更低;90天全因死亡率两组无显著差异(2.7% vs 4.0%,P=1.000)。
要点
- 在≥80岁长期机械通气患者中,多组分肺康复组成功脱机率45.3%,标准康复组12.0%(校正HR 5.11;95%CI 2.46-11.23;P<.001)。
- 干预组在30、60、90天时氧饱和度、膈肌增厚分数、咳嗽强度和肌力达到预设改善标准的 odds 更高。
- VAP发生率在60天和90天时干预组更低;90天全因死亡率两组无显著差异(2.7% vs 4.0%,P=1.000)。
- 深静脉血栓发生率两组无显著差异;Fine-Gray竞争风险分析亚分布HR 4.45(95%CI 2.11-9.36;P<.001)。
- 该研究为单中心、评估者盲法RCT,意向性分析每组75例,结论需多中心验证。
适用人群与场景
- ≥80岁接受长期机械通气的患者,来自中国解放军总医院单中心。
诊断标准与关键阈值
- 原文未提及长期机械通气的具体定义或时长阈值。
- 主要终点成功脱机;次要终点包括脱机时氧饱和度、膈肌增厚分数、咳嗽能力、肌力及VAP发生率,在30、60、90天评估;DVT在90天或参与结束时评估。
- 预设改善标准的具体界值原文未提及。
处置流程与药物剂量
- 干预为多组分肺康复方案,对照组为标准康复;具体组分、频次、疗程及实施细节原文未提及。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 单中心、评估者盲法随机对照试验,意向性分析每组75例。
- 主要终点:多组分肺康复组成功脱机45.3%,标准康复组12.0%(校正HR 5.11;95%CI 2.46-11.23;P<.001)。
- 次要终点:干预组在30、60、90天达到氧饱和度、膈肌增厚分数、咳嗽强度、肌力预设改善标准的 odds 更高;60天和90天VAP发生率更低;DVT发生率两组无显著差异。
- 90天全因死亡率:干预组2.7%(2/75),对照组4.0%(3/75),P=1.000。
- Fine-Gray竞争风险分析亚分布HR 4.45(95%CI 2.11-9.36;P<.001);符合方案分析结果相似。
证据类型、等级与局限
- 随机对照试验(RCT),单中心、评估者盲法。
- 局限:单中心,样本量每组75例,长期机械通气定义及康复方案细节未详述。
对床旁实践的改变
- 对≥80岁长期机械通气患者,可考虑实施多组分肺康复以促进脱机,但需注意该证据来自单中心RCT,方案细节未完全公开。
指南或共识出处
- 原文未提及指南或共识;临床试验注册:Chinese Clinical Trial Registry ChiCTR2100050342。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Older patients receiving prolonged mechanical ventilation (MV) have a low likelihood of successful ventilator liberation and remain at risk of infectious complications and death.
RESEARCH QUESTION: In patients ≥ 80 years of age receiving prolonged MV, does a multicomponent pulmonary rehabilitation program increase successful weaning?
STUDY DESIGN AND METHODS: This single-center, assessor-masked randomized controlled trial was conducted at Chinese PLA General Hospital. Patients ≥ 80 years of age receiving prolonged MV were randomized to multicomponent pulmonary rehabilitation or standard rehabilitation. The primary outcome was successful weaning. Secondary outcomes were oxygen saturation while not receiving MV, diaphragm thickening fraction, cough ability, muscle strength, and the incidence of ventilator-associated pneumonia (VAP) assessed at 30, 60, and 90 days. Deep vein thrombosis (DVT) was assessed at day 90 or when participation ended.
RESULTS: The intention-to-treat analysis included 75 patients in each group. Among patients who received the multicomponent pulmonary rehabilitation program, 45.3% achieved successful weaning, compared with 12.0% among patients receiving standard rehabilitation (adjusted hazard ratio [HR], 5.11; 95% CI, 2.46-11.23; P < .001). No significant difference was found in the incidence of DVT between the 2 groups. The intervention group showed higher odds of meeting the prespecified improvement criteria for oxygen saturation, diaphragm thickening fraction, cough strength, and muscle strength at 30, 60, and 90 days, whereas VAP incidence was lower at days 60 and 90. The all-cause mortality rate at 90 days was 2.7% (2/75) in the trial group and 4.0% (3/75) in the control group (P = 1.000). The per-protocol analysis yielded similar results. The Fine-Gray competing risk analysis yielded a subdistribution HR of 4.45 (95% CI, 2.11-9.36; P < .001).
INTERPRETATION: Our results show that in patients ≥ 80 years of age receiving prolonged MV, the multicomponent pulmonary rehabilitation program improved physiologic recovery and significantly increased successful weaning.
CLINICAL TRIAL REGISTRATION: Chinese Clinical Trial Registry; No.: ChiCTR2100050342; URL: www.chictr.org.cn.
参考来源
- Liu T, Kou T, Wei G, et al. Multicomponent Pulmonary Rehabilitation for Prolonged Mechanical Ventilation in Patients 80 Years of Age or Older: A Randomized Controlled Trial. Chest. 2026. PMID: 42762982. doi:10.1016/j.chest.2026.08.050
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。